abstract |
The present invention provides compositions that inhibit undesirable angiogenesis such as retinopathy and endometriosis. Propanoic acid (2,5-dioxopyrrol-1-yl) methyl (NSC19630), 1-benzylsulfonyl-2,4-dinitrobenzene (NSC122657), isobutyric acid maytansinol (NSC292222), chloroplatinum (1+); 2- (4-methylpiperidin-1-yl) ethanethiolate; a dehydrate (NSC292596), or a composition comprising at least one pharmaceutically acceptable salt thereof; [(4-Arsononophenyl) methyl] phenyl] arsonic acid (NSC48300) or a pharmaceutically acceptable salt thereof. [Selection figure] None |